

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Sodium Tetradecyl Sulfate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency
Details : Sodium Tetradecyl Sulfate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Venous Insufficiency.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 17, 2017
Lead Product(s) : Sodium Tetradecyl Sulfate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
